Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Pharmaids Pharmaceuticals Limited (PHARMAID.BO)

Compare
65.99
-1.39
(-2.06%)
At close: 3:29:29 PM GMT+5:30
Loading Chart for PHARMAID.BO
  • Previous Close 67.38
  • Open 68.00
  • Bid 65.55 x --
  • Ask 66.00 x --
  • Day's Range 65.55 - 68.00
  • 52 Week Range 57.99 - 84.97
  • Volume 3,040
  • Avg. Volume 8,650
  • Market Cap (intraday) 2.327B
  • Beta (5Y Monthly) 0.33
  • PE Ratio (TTM) --
  • EPS (TTM) -3.85
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Pharmaids Pharmaceuticals Limited, together with its subsidiaries, provides specialty chemicals, skin care and hospital care products, and generics in India. The company offers specialty chemicals, including retinol, DL alpha tocopherol, D pantothenate, cyanocobalamin, pyridoxine Hcl, thiamine, nicotinic acid, water sol. vitamin E, coenzyme Q10, and D-biotin; and skin care products, such as best care hands, hands sanitizers, moisturizing creams, skinsure plus, skinsure ultra, alcohol gels, and barrier creams. It also provides hospital care products comprising hand rubs and gel, skin antiseptics, and general antiseptics and disinfectants; and generic products in the areas of orthopedic, neuro, and gastro, etc. In addition, the company offers contract research and manufacturing services. Pharmaids Pharmaceuticals Limited was incorporated in 1989 and is based in Bengaluru, India.

www.pharmaids.com

25

Full Time Employees

March 31

Fiscal Year Ends

Recent News: PHARMAID.BO

View More

Performance Overview: PHARMAID.BO

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

PHARMAID.BO
6.37%
S&P BSE SENSEX (^BSESN)
1.40%

1-Year Return

PHARMAID.BO
1.70%
S&P BSE SENSEX (^BSESN)
5.62%

3-Year Return

PHARMAID.BO
1.70%
S&P BSE SENSEX (^BSESN)
32.06%

5-Year Return

PHARMAID.BO
1.70%
S&P BSE SENSEX (^BSESN)
151.76%

Compare To: PHARMAID.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHARMAID.BO

View More

Valuation Measures

Annual
As of 4/15/2025
  • Market Cap

    2.38B

  • Enterprise Value

    2.49B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.12

  • Price/Book (mrq)

    3.54

  • Enterprise Value/Revenue

    8.52

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -38.18%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    297.71M

  • Net Income Avi to Common (ttm)

    -113.67M

  • Diluted EPS (ttm)

    -3.85

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    27.92M

  • Total Debt/Equity (mrq)

    22.30%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PHARMAID.BO

View More

Company Insights: PHARMAID.BO

Research Reports: PHARMAID.BO

View More

People Also Watch